PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies

Salvatore De Cosmo; Sabrina Prudente; Olga Lamacchia; Emanuela Lapice; Eleonora Morini; Rosa Di Paola; Massimiliano Copetti; Piero Ruggenenti; Giuseppe Remuzzi; Olga Vaccaro; Mauro Cignarelli; Vincenzo Trischitta

doi:10.1093/ndt/gfr187

Related publications

Article2012

Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes

Piero Ruggenenti, Esteban Porrini, Nicola Motterlini, Annalisa Perna, Aneliya Parvanova, Ilian Iliev, Alessandro Roberto Dodesini, Roberto Trevisan, Antonio Bossi, Giuseppe Sampietro, Enrica Capitoni, Flavio Gaspari, Nadia Rubis, Bogdan Ene‐Iordache, Giuseppe Remuzzi

Article2015

Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies

Zhilei Shan, Hongfei Ma, Manling Xie, Peipei Yan, Yanjun Guo, Wei Bao, Rong Ying, Chandra L. Jackson, Frank B Hu, Liegang Liu

Article2003

Prospective Study of the Association Between the Proline to Alanine Codon 12 Polymorphism in the PPARγ Gene and Type 2 Diabetes

Aslı Memişoğlu, Frank B Hu, Susan E. Hankinson, Simin Liu, James B. Meigs, David Altshuler, David J. Hunter, JoAnn E. Manson

Article2009

Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT

Salvatore De Cosmo, Nicola Motterlini, Sabrina Prudente, Fabio Pellegrini, Roberto Trevisan, Antonio Bossi, Giuseppe Remuzzi, Vincenzo Trischitta, Piero Ruggenenti

Article2007

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy

Wouter B.A. Eijkelkamp, Zhongxin Zhang, Giuseppe Remuzzi, Hans‐Henrik Parving, Mark E. Cooper, William F. Keane, Shahnaz Shahinfar, Gilbert W. Gleim, Barry M. Brenner, Dick de Zeeuw

PPAR 2 P12A polymorphism and albuminuria in patients with type 2 diabetes: a meta-analysis of case-control studies

Abstract

Discussion(0)

Related publications

Measurable Urinary Albumin Predicts Cardiovascular Risk among Normoalbuminuric Patients with Type 2 Diabetes

Sleep Duration and Risk of Type 2 Diabetes: A Meta-analysis of Prospective Studies

Prospective Study of the Association Between the Proline to Alanine Codon 12 Polymorphism in the <i>PPAR</i>γ Gene and Type 2 Diabetes

Impact of the <i>PPAR</i>-γ<i>2</i> Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT

Albuminuria Is a Target for Renoprotective Therapy Independent from Blood Pressure in Patients with Type 2 Diabetic Nephropathy